info@salutesicilia.com

Ovary cancer eludes immunity? Chemical databases will show a natural way to hinge with

Ovary cancer eludes immunity? Chemical databases will show a natural way to hinge with

Medicomunicare

Due to the development of resistance to chemotherapy and recurring tumors, patients with ovarian cancer often have low survival rates. Even the immunotherapy, sometimes, is not deveoided of insuccesses; therefore, new therapeutic options such as targeted therapy that boosts antitumor immunity are needed to improve treatment efficacy and patient survival. In a research published a couple of

Read More